(Q41084045)

26 September 2017

title

Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species (English)

1 reference

26 September 2017

7

1 reference

26 September 2017

Sahaf B

1

1 reference

26 September 2017

Söderberg A

2

1 reference

26 September 2017

Spyrou G

3

1 reference

26 September 2017

Barral AM

4

1 reference

26 September 2017

Pekkari K

5

1 reference

26 September 2017

Holmgren A

6

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Experimental Cell Research

26 September 2017

published in

1 reference

26 September 2017

volume

236

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

181-192

1 reference

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

26 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910260208

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910170504

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/270347A0

The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Elevation of plasma thioredoxin levels in HIV-infected individuals

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Thioredoxin, a mediator of growth inhibition, maps to 9q31

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Effects of adult T-cell leukaemia-derived factor on ultraviolet radiation-induced skin injury

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Characterization of a thioredoxin-related surface protein

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Alternative forms of the human thioredoxin mRNA: identification and characterization

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Rat liver thioredoxin and thioredoxin reductase: purification and characterization

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/EXCR.1997.3699

Identifiers

DOI

10.1006/EXCR.1997.3699

1 reference

26 September 2017

1 reference